From the Editor's Desk

US drugs regulator gives LSD ‘breakthrough’ status for treating anxiety – why this is so significant

LSD was accidentally discovered by Albert Hofmann at the Sandoz pharmaceutical company in Switzerland in 1938. It was apparently useless, but from 1947 it was marketed as “a cure for everything from schizophrenia to criminal behavior, ‘sexual perversions’, and alcoholism”. It failed to find its niche.

Now, over 80 years later, it may finally have found one – other than expanding consciousness, that is. A new study shows that it is highly effective at treating generalised anxiety disorder for up to 12 weeks with just a single dose. And it is fast acting.

Continued here

TradeBriefs: Newsletters for Decision-Makers!

Our advertisers help fund the daily operations of TradeBriefs. We request you to accept our promotional emails.

Want the newsletters, without the promotional mailers?
Get an (ad-free) subscription to TradeBriefs Premium for just $1 per month.